Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19.

Contemp Clin Trials · 2020 · PMC7486285 · PMID 32927092

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

Note that the difference in mean event-free survival is highly statistically significant in favor of remdesivir in contrast to the moderately significant difference obtained using the duration of the need for medical attention.

also in 2,178 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.